Hemispherx (HEB) Reports Q4 Loss of $0.02/Share
Tweet
Share
E-mailGet Alerts HEB Hot Sheet
Price: $1.80 --0%
Financial Fact:
Total costs and expenses: 2.83M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Total costs and expenses: 2.83M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Hemispherx Biopharma, Inc. (NYSE: HEB) reported Q4 EPS of ($0.02). Revenue for the quarter came in at $38 thousand.
For earnings history and earnings-related data on Hemispherx Biopharma, Inc. (HEB) click here.
For earnings history and earnings-related data on Hemispherx Biopharma, Inc. (HEB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fox upgraded to overweight as Roku deal, ad strength lift outlook
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
- Wolverine World Wide (WWW) PT Raised to $26 at Stifel as Multiple Can Move Higher
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
